Skip to main content

UN court upholds life sentence for 'Butcher of Bosnia' Mladic

 The verdict by five judges at the UN International Residual Mechanism for Criminal Tribunals is final and cannot be appealed any further.

Former Bosnian Serb military leader Ratko Mladic stands prior to the pronouncement of his appeal judgement
at the UN tribunal in The Hague on June 8, 2021. (Reuters)

The UN court has upheld genocide and war crimes convictions of former Bosnian Serb military chief Ratko Mladic for the 1995 Srebrenica massacre and dismissed his appeal.

UN judges in The Hague ruled on Tuesday on an appeal by the so-called "Butcher of Bosnia" against his 2017 conviction and life sentence for genocide, war crimes and crimes against humanity during the 1992-95 Bosnia war.

The verdict by five judges at the UN International Residual Mechanism for Criminal Tribunals – which deals with cases from the now-closed Yugoslavia war crimes tribunal – is final and cannot be appealed any further.


Comments

Popular posts from this blog

NATO Chief: No New Cold War With China

Flags of NATO member countries flutter at alliance headquarters in Brussels, Belgium, February 28, 2020. REUTERS/Francois Lenoir/File Photo NATO Secretary General Jens Stoltenberg said Monday there is no new Cold War with China but the western allies will have to adapt to the challenge of Beijing's rise. "We're not entering a new Cold War and China is not our adversary, not our enemy," Stoltenberg told reporters after a NATO leaders' summit. "But we need to address together, as the alliance, the challenges that the rise of China poses to our security." NATO leaders are expected on Monday to brand China as a security risk to the Western alliance for the first time, a day after the Group of Seven issued a statement on human rights and Taiwan that Beijing said slandered its reputation. G7 leaders, meeting in Britain over the weekend, scolded China over human rights in its Xinjiang region, called for Hong Kong to keep a high degree of autonomy and demanded a...

Can Biden-Erdogan meeting break the diplomatic impasse on key issues?

Turkey is a US ally and a NATO member, but under President Erdogan’s assertive foreign policy, Ankara has shown the capacity to go its own way if necessary. American and Turkish leaders, Joe Biden and Recep Tayyip Erdogan, will meet on June 14 at the NATO summit amid a backdrop of serious disagreements on various issues, ranging from Ankara’s purchase of Russian S-400s to Washington’s ongoing support of the YPG, the Syrian wing of the PKK, a terror group in northern Syria. There are also other issues like Biden’s recent acceptance of the 1915 incidents concerning armed fighting between Armenians and Turks during WWI as a genocide, and Washington’s previous criticism of Turkey’s assertive eastern Mediterranean policy. Despite those differences, Turkey and the US continue to have close commercial relations and across Central Asia and the Caucasus, both countries have similar political stances. Ankara, like Washington, has been also opposing Russian intervention in both the Ukrainian and ...

EU Advises Against Astrazeneca Shot in People With Rare Blood Condition

A vial of AstraZeneca coronavirus vaccine is seen at a vaccination center in Westfield Stratford City shopping center, amid the outbreak of coronavirus disease (COVID-19), in London, Britain, February 18, 2021. (REUTERS/Henry Nicholls) Europe's drug regulator on Friday advised against using AstraZeneca's COVID-19 vaccine in people with a history of a rare bleeding condition and said it was looking into heart inflammation cases after inoculation with all coronavirus shots. The European Medicines Agency's (EMA) safety committee in its evaluation said that capillary leak syndrome must be added as a new side effect to labelling on AstraZeneca's vaccine, Reuters reported. It is a condition in which blood leaks from the smallest of vessels into muscles and body cavities and is characterized by swelling and a drop in blood pressure. The regulator first began looking into these cases in April and the recommendation adds to AstraZeneca's woes after its vaccine has been dogge...